Andreas Struengmann was born in Tegernsee, Germany, Germany. In 2005, Andreas Struengmann and his twin brother, Thomas, who together founded generic drug maker Hexal AG in 1986, sold the business (along with their 68% stake in U.S.-based Eon Labs) to Novartis for $7.5 billion. Since then, they've been actively investing in biotechnology and pharmaceutical companies. Their holdings also include a private bank, Stuttgart-based Sudwestbank. In 2008, they established a neuroscience research center in Frankfurt named after their father, Ernst Struengmann. After studying medicine in Freiburg, Germany, Andreas worked as a doctor in South Africa. He is known to love sailing, golf and skiing.
Andreas Struengmann is a member of Health care
